Skip to Main Content
chevron-right
chevron-left
chevron-down
chevron-up
chevron-circle-up
chevron-circle-right
chevron-circle-down
chevron-circle-left
Facebook Logo
Twitter Logo
Linkedin Logo
Youtube Logo
Google Plus Logo
Vimeo Logo
Issuu Logo
Right arrow
Left arrow
Location
Search
Mail
Phone
Our Services
Personal Care and Support
Respite Care
Alzheimers & Dementia Care
HomeLife Enrichment
Careers
Education Center
Resources
Stories From Home
Our Community
About Us
Home Care Service Area
Contact Us
Blog
Facebook
LinkedIn
Twitter
Youtube
Newsletter
Location Icon
Shrewsbury MA
364 Boston Turnpike, Shrewsbury, MA 01545
(508) 444-0270
Life Extension
Posted: 12/8/2016 11:13 AM by
Interim HealthCare
How long do you want to live? What if science created a treatment that could help you live longer and healthier? It's not science-fiction, and it may be available sooner than you think.
Researchers at the Mayo Clinic, the Scripps Institute, and other institutions have created a new class of drugs to slow the aging process in mice. These drugs, known as senolytics, not only added lifespan, but they also reduced frailty.
So what do these drugs do?
According to Professor Paul Robbins and Associate Professor Laura Niedernhofer who led research efforts for the new study at Scripps Florida, senolytics target senescent cells, the ones which have stopped dividing and accumulate as we age, accelerating the ageing process. If our cells can continue to divide, the aging process, and natural aging conditions can be slowed, or even reversed.
"In animal models, the compounds improved cardiovascular function and exercise endurance, reduced osteoporosis and frailty, and extended healthspan," said Niedernhofer. "Remarkably, in some cases, these drugs did so with only a single course of treatment."
In the mice, the effect of a single treatment lasted at least seven months.
But what does this mean for humans?
Of course more testing will need to be done to better understand the side effects of the drugs in long-term use, but Mayo Clinic Professor James Kirkland, MD, PhD, the senior author of the study is hopeful. "It may eventually become feasible to delay, prevent, alleviate or even reverse multiple chronic diseases and disabilities as a group, instead of just one at a time."
Recently, President Obama announced that he would ask Congress to designate funds for research into utilizing the human genome to target prevention and treatment of the most common disabling diseases in Americans, Heart Disease, Diabetes and Cancer.
If the new government funding is approved, Reversal of aging and degenerative disease is possible, perhaps sooner than we think.